HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques

Cardiovascular Pathology

Volumn 16, Issue 3, 2007, Pages 136-143

  Inoue, Katsumi ^a   Kawahara, Ko ichi ^b   Biswas, Kamal Krishna ^b   Ando, Kenji ^c   Mitsudo, Kazuaki ^a   Nobuyoshi, Masakiyo ^c   Maruyama, Ikuro ^b  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; High mobility group box 1; Inflammation; Plaque instability; Smooth muscle cells

Indexed keywords

C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; STROMELYSIN;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CELLS, CULTURED; CORONARY ARTERIOSCLEROSIS; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASES; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER;

EID: 34248342982     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2006.11.006     Document Type: Article

References (36)

1. Bianchi M., and Beltram M. Flexing DNA: HMG-box proteins and their partners. Am Hum Genet 63 (1998) 1573-1577
2. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
3. Yang H., Wang H., and Tracey K. HMG-1 rediscovered as a cytokine. Shock 15 (2001) 247-253
4. Andersson U., Wang H., Palmblad K., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192 (2000) 565-570
5. Taniguchi N., Kawahara K., Yone K., et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48 (2003) 971-981
6. Hori O., Brett J., Slattery T., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. J Biol Chem 270 (1995) 25752-25761
7. Schmidt A., Yan S., Yan S., et al. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498 (2000) 99-111
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
9. Kalinina N., Agrotis A., Antropova Y., et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 24 (2004) 1-7
10. Verma S., Li S.-H., Badiwara M., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105 (2002) 1890-1896
11. Calabró P., Willerson J., and Yeh E. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 (2003) 1930-1932
12. Ozaki K., Inoue K., Sato H., et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 429 (2004) 72-75
13. Yamada S., Inoue K., Yakabe K., et al. High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 49 (2003) 1535-1537
14. Shi S.-R., Key M., and Kalra K. Antigen retrieval in forunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39 (1991) 741-748
15. Aikawa M., Sakomura Y., Ueda M., et al. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 96 (1997) 82-90
16. Kawahara K., Watanabe S., Ohshima T., et al. Hypernuclear acetylation in atherosclerotic lesions and activated vascular smooth muscle cells. Biochem Biophys Res Commun 266 (1999) 417-424
17. Andersson U., Erlandsson-Harris H., Yang H., and Tracey K. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72 (2002) 1084-1091
18. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
19. Taguchi A., Blood D., Torodel G., et al. Blockade of RAGE-amphoterin signalling suppresses tumor growth and metastases. Nature 405 (2000) 354-360
20. Kuro-o M., Nagai R., Nakahara K., et al. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in atherosclerosis. J Biol Chem 266 (1991) 3768-3773
21. Simons M., Leclerc G., Safian R., et al. Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. N Engl J Med 328 (1993) 608-613
22. Thurberg B., and Collins T. The nuclear factor-κB/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 9 (1998) 387-396
23. Han Y., Runge M., and Brasier A. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotrophic activation of nuclear factor-κB transcription factors. Circ Res 84 (1999) 695-703
24. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
25. Blake G., and Ridker P. Novel clinical markers of vascular wall inflammation. Circ Res 89 (2001) 763-771
26. Isikawa T., Hatakeyama K., and Imamura T. Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol 91 (2003) 287-292
27. Balloon S., and Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4 (1992) 361-368
28. Pasheva E., Sarov M., Bidjekov K., et al. In vitro acetylation of HMGB-1 and -2 proteins by CBP: the role of the acidic tail. Biochemistry 43 (2004) 2935-2940
29. Bonaldi T., Talamo F., Scaffidi P., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22 (2003) 5551-5560
30. Dollery C., McEwan J., and Henney A. Matrix metalloproteinases and cardiovascular diseases. Circ Res 77 (1995) 863-868
31. Galis Z., Muszynski M., and Sukhova G. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75 (1994) 181-189
32. Bendeck M., Zempo N., Clowes A., et al. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75 (1994) 539-545
33. Degryse B., Bonaldi T., Scaffidi P., et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152 (2001) 1197-1206
34. Lee R., and Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 17 (1997) 1859-1867
35. Galis Z., Sukhova G., Lark M., and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94 (1994) 2493-2503
36. Brown D., Hibbs M., Kearney M., et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 91 (1995) 2125-2131